We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Safety and Efficacy Results From CRISPR/Cas9 Human Clinical Trials Are Positive

News   Nov 21, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
Safety and Efficacy Results From CRISPR/Cas9 Human Clinical Trials Are Positive
 
 
 

RELATED ARTICLES

HIV Vaccine Efficacy Impacted by Rectal Microbes

News

Microbes living in the rectum could make a difference to the effectiveness of experimental HIV vaccines.

READ MORE

Largest Study of Its Kind Finds Many Psychiatric Disorders Arise From the Same Genes

News

In the largest-ever study of its kind researchers identified more than 100 genetic variants that affect the risk for more than one mental health condition.

READ MORE

Can Genetic Testing Predict Opioid Addiction Risk?

News

A new partnership will focus on novel genetic testing technology designed to objectively assess an individual's risk of opioid addiction prior to opioid exposure. The clinical research will be conducted with patients in The Netherlands to confirm that the positive results from research completed in the United States are also found in the Dutch health care system.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE